About the Authors
- Luca Giliberto
-
Current address: The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research, North Shore – LIJ, Manhasset, New York, United States of America
Affiliation Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Shuji Matsuda
-
Affiliation Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, United States of America
- Ruben Vidal
-
Affiliation Department of Pathology and Laboratory Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Luciano D'Adamio
-
* E-mail: luciano.dadamio@einstein.yu.edu
Affiliation Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, United States of America
Competing Interests
LG and LD are inventors of an AECOM patent on the FDD mice. The mice discussed in this paper (BRI2-ADan knock-in mice) are patent-pending. The assign is the Albert Einstein College of Medicine. The Albert Einstein College of Medicine has licensed the patent to a Biotech company (Remegenix) of which Dr. D'Adamio is a co-founder. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors http://www.plosone.org/static/policies.action#sharing.
Author Contributions
Conceived and designed the experiments: LD. Performed the experiments: LG SM RV. Analyzed the data: LG RV LD. Wrote the paper: RV LD.